Roche BLACK BOX warning16 Nov 2017 18:41
1. Most of Shire�s advance came in the minutes before Roche announced that its potentially game-changing treatment for haemophilia, Shire�s biggest market by revenue, will in the US be required to include a boxed safety warning on its label.
2. Another explanation for Shire�s strength came in a Bernstein sector note, which argued that, while consensus expectations are still too high, the stock is looking increasingly good value.
3. The demand also gave traders an excuse to retread takeover speculation: Shire is 41 per cent cheaper in US dollar terms since October 2014 when AbbVie was forced to abandon a $55bn takeover.